What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Amino acid
His primary areas of study are Internal medicine, Endocrinology, Prolactin receptor, Prolactin and Receptor.
His studies in Mammary gland, Growth hormone receptor, Insulin, Hormone and Cell surface receptor are all subfields of Internal medicine research.
His Endocrinology study combines topics in areas such as Placental lactogen, Cancer research, Messenger RNA and Binding site.
Paul A. Kelly has included themes like Tyrosine kinase, Gene expression, Molecular biology and Null allele in his Prolactin receptor study.
Paul A. Kelly combines subjects such as Hypophysectomy, Estrogen and In vivo with his study of Prolactin.
His Receptor study incorporates themes from Wild type, Reporter gene and Signal transduction.
His most cited work include:
- Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice (1550 citations)
- The prolactin/growth hormone receptor family. (702 citations)
- Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. (535 citations)
What are the main themes of his work throughout his whole career to date?
Paul A. Kelly focuses on Internal medicine, Endocrinology, Receptor, Prolactin receptor and Prolactin.
The concepts of his Internal medicine study are interwoven with issues in Placental lactogen, Cell culture and Null allele.
His Endocrinology research integrates issues from Cancer research, Lactation and Autocrine signalling.
His study focuses on the intersection of Receptor and fields such as Signal transduction with connections in the field of Phosphorylation.
The Prolactin receptor study combines topics in areas such as Amino acid, Gene expression, Molecular biology, Knockout mouse and Messenger RNA.
The Prolactin study combines topics in areas such as Antibody, Monoclonal antibody, Dopamine and Mammary gland.
He most often published in these fields:
- Internal medicine (62.86%)
- Endocrinology (62.45%)
- Receptor (48.98%)
What were the highlights of his more recent work (between 2001-2021)?
- Internal medicine (62.86%)
- Endocrinology (62.45%)
- Prolactin (51.84%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Endocrinology, Prolactin, Receptor and Prolactin receptor.
His Internal medicine research integrates issues from Gene expression and Transgene.
His research in Endocrinology intersects with topics in Cancer research, Lactation and Mammary gland.
The various areas that Paul A. Kelly examines in his Prolactin study include Amino acid, Autocrine signalling, Null allele and Endocrine system.
His research integrates issues of Dopamine, Pharmacology and Binding site in his study of Receptor.
His Prolactin receptor study integrates concerns from other disciplines, such as Prostate, Antagonist, Wild type, Knockout mouse and In vivo.
Between 2001 and 2021, his most popular works were:
- PROLACTIN: The New Biology of an Old Hormone (331 citations)
- Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. (203 citations)
- Development and potential clinical uses of human prolactin receptor antagonists. (170 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
